Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents by Roeker, Lindsey E., Dreger, Peter, Brown, Jennifer R., Lahoud, Oscar B., Eyre, Toby A., Brander, Danielle M., Skarbnik, Alan, Coombs, Catherine C., Kim, Haesook T., Davids, Matthew, Manchini, Steven T., George, Gemlyn, Shah, Nirav, Voorhees, Timothy J., Orchard, Kim H., Walter, Harriet S., Arumainathan, Arvind K., Sitlinger, Andrea, Park, Jae H., Geyer, Mark B., Zelenetz, Andrew D., Sauter, Craig S., Giralt, Sergio A., Perales, Miguel-Angel, Mato, Anthony R.

Get full text

Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial by Chaganti, Sridhar, Maycock, Shanna, McIlroy, Graham, Iqbal, Waleed A, Mason, John, Kanfer, Edward, Kassam, Shireen, Cwynarski, Kate, Wrench, David, Arumainathan, Arvind K., Fox, Christopher P, Johnson, Rod, McKay, Pam, Paneesha, Shankara, Rowntree, Clare J, Balotis, Constantine-George, Collins, Graham P., Davies, Andrew, Wright, Josh, Wheatley, Keith, Menne, Tobias F

Get full text

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents by Roeker, Lindsey E., Brown, Jennifer R., Dreger, Peter, Lahoud, Oscar B, Eyre, Toby A., Brander, Danielle M., Skarbnik, Alan, Coombs, Catherine C., Kim, Haesook T., Manchini, Steven T, Voorhees, Timothy J, Orchard, Kim H., Walter, Harriet S, Arumainathan, Arvind K., Sitlinger, Andrea, Sauter, Craig S., Giralt, Sergio A, Perales, Miguel-Angel, Mato, Anthony R.

Get full text